C4 Therapeutics, Inc. earnings per share and revenue

CCCC earnings per share for the last quarter are -0.68 USD whereas the estimation was -0.69 USD which accounts for 1.01% surprise. Company revenue for the same period amounts to 3.27 M USD despite the estimated figure of 3.20 M USD. Estimated earnings per share for the next quarter are -0.36 USD, and revenue is expected to reach 11.99 M USD. Also watch annual changes over time to get a bigger picture of CCCC earnings per share and revenue dynamics.